ADAS3D Medical Secures Chinese NMPA Approval for Software Distribution

Exciting news! #ADAS3D has officially secured Chinese NMPA approval, marking a significant milestone for our team. This approval allows us to reinforce ADAS3D’s expansion in this important market. 

Image
NMPA unveils groundbreaking quality standards for Medical Device Operations in China, prioritizing public safety and industry standardization.

Nota:

ADAS3D Medical Secures Chinese NMPA Approval for Software Distribution

Barcelona, January 18 2024 – ADAS3D Medical, a leading innovator in medical software solutions, proudly announces the recent approval granted by the Chinese National Medical Products Administration (NMPA) to distribute its advanced software throughout China. The official authorization, issued on December 27, marks a significant milestone for the company, enabling the widespread deployment of its cutting-edge solution across the entire Chinese territory.

ADAS 3D is an advanced software for electrophysiologists that uses CT and MRI to plan procedures. The software’s results can be imported into navigation systems, providing a road map to supplement electro-anatomical mapping, making navigation and targeting easier. Users of ADAS3D will benefit from the seamless transformation of CTA and DE-MRI images into detailed 3D analyses.

The approval to commence commercialization in China signifies the success of ADAS3D’s sets the stage for the commercial growth, strategically positioned to address the substantial number of patients in China grappling with heart disease. Highlighting the immense potential, the Business Director Jacobo Gil de Biedma added, “The approval by the NMPA is outstanding news for ADAS3D. We are thrilled to have reached this pivotal point in our international growth strategy.”

As our goal remains to improve cardiovascular care by making Cardiac Imaging (MRI and CT) more accessible and effective for electrophysiology procedures, the NMPA approval signifies a key milestone in its mission to make a positive impact on medical procedures in China.


For more information about ADAS3D and its solutions, contact info@adas3d.com.

Share:

Start now with a free Demo

Let us support you through all the steps of your patient care.

Latest Tweets:

Data controller: ADAS3D MEDICAL, SL +info
Purpose of the data processing: Response to a contact request from a user. +info
Legitimacy of data processing: Legitimate interest in responding to contact requests received through the web. +info
Recipients of assignments or transfers: No international transfers or assignments are made. +info
Rights of the data subject: Access, rectify and delete your data, as well as to exercise other rights as set out in the additional information. +info
Additional information: Additional and detailed information on data protection can be found in the individual links of each of the reported sections. +info
Data controller: ADAS3D MEDICAL, SL +info
Purpose of the data processing: Management of CV’s received through the “Work with us” section. +info
Legitimacy of data processing: Unambiguous consent of the data subject. +info
Recipients of assignments or transfers: No international transfers or assignments are made. +info
Rights of the data subject: Access, rectify and delete your data, as well as to exercise other rights as set out in the additional information. +info
Additional information: Additional and detailed information on data protection can be found in the individual links of each of the reported sections. +info
Data controller: ADAS3D MEDICAL, SL +info
Purpose of the data processing: Response to a contact request for the purpose of receiving a demo from a potential customer or user. +info
Legitimacy of data processing: Legitimate interest in responding to a request for a demo of the product marketed by the company. +info
Recipients of assignments or transfers: No international transfers or assignments are made. +info
Rights of the data subject: Access, rectify and delete your data, as well as to exercise other rights as set out in the additional information. +info
Additional information: Additional and detailed information on data protection can be found in the individual links of each of the reported sections. +info